Article

Significance of lead aVR ST segment elevation in acute coronary syndrome.

Department of Cardiology, Cardiac Unit, Chest Disease Institute, Nonthaburi, Thailand.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 10/2005; 88(10):1382-7.
Source: PubMed

ABSTRACT To study the relation between lead aVR ST segment elevation (aVRSTE) and angiographic_coronary artery lesions in patients with acute coronary syndrome (ACS).
From January 2001 to December 2001, the authors retrospectively studied 26 consecutive patients who were admitted to the coronary care unit, Chest Disease Institute with ACS. The admission 12-lead EKGs,chest X-ray, troponin T, creatine phosphokinase (CPK), creatine kinase MB fraction (CK MB) and blood chemistry including fasting blood sugar, renal function test (BUN and creatinine), electrolytes and lipid profiles were obtained and analyzed before coronary angiogram. CAG was performed in all within 48 hours after admission. The admission 12-lead EKGs and angiographic coronary artery lesions were analyzed.
There were 26 patients (M:F = 21:5) with a mean age of 64 +/- 9 yr. The culprit lesions were located at the left main coronary artery (LM) in 5 (19%), the left anterior descending artery (LAD) in 8 (31%), the right coronary artery (RCA) in 11 (42%) and the left circumflex artery (LCX) in 2 (8%). Of these, aVRSTE (> 0.1 mV) was detected in 9 (35%), 4 in the LM group (80%). 3 in the RCA group (27%) and 2 in the LAD group (25%). The findings of aVRSTE distinguished the LM group from the non LM group (LAD, RCA and LCX), with 80% sensitivity, 76% specificity and 77% accuracy.
In patients with acute coronary syndrome, lead AVR ST segment elevation is associated with the culprit left main coronary lesion.

Download full-text

Full-text

Available from: Kriengkrai Hengrussamee, Jun 20, 2015
1 Follower
 · 
306 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: ST segment elevation and deviation in lead aVR can provide useful prognostic information in patients with ST elevation myocardial infarction (STEMI). The aim of the present study was evaluation of the effect of aVR ST elevation (aVR-STE) and aVR ST deviation (aVR-STD) the in-hospital and six-month prognosis of patients with STEMI. Methods: The study was a cohort of medically treated patients with acute STEMI. The patients were categorized as aVR ST elevation (aVR-STE) or aVR ST deviation (aVR-STD) if there was > 0.05 mv ST elevation or ST deviation in lead aVR, respectively; otherwise, they were categorized as control groups. Results: 334 patients [49 patients (14.67%) with aVR-STE and 159 patients (47.60%) with aVR-STD] were included. The mean age of the study group was 59.62 ± 13.03 years and 75.4% were male. In-hospital mortality was not significantly different in patients with or without aVR-STE or aVR-STD. Pulmonary edema or overt decompensated heart failure was seen more in patients with aVR-STE [Relative risk (RR): 3.393, 95% confidence interval: 1.405-8.192, P = 0.012] and it trended more in patients with aVR-STD (P = 0.06). 6-month follow up: Mortality was not significantly different among patients with or without aVR-STE or aVR-STD. Pulmonary edema or overt decompensated heart failure occurred more in patients with aVR-STE and aVR-STD (RR: 3.190, 95% confidence interval: 1.684-6.046, P < 0.0001, RR: 1.937, 95% confidence interval: 0.987-3.800, P = 0.049). Conclusion: ST elevation or deviation in lead aVR was not an indicator of in-hospital and six-month mortality in our study. However, its effect on pulmonary edema or overt decompensated heart failure requires more study. Keywords: ST elevation myocardial infarction; Electrocardiography; Prognosis; ST segment elevation in lead aVR
  • [Show abstract] [Hide abstract]
    ABSTRACT: Several studies suggest that electrocardiographers tend to neglect lead aVR during the reading of electrocardiograms (ECGs). Our objective was to provide a systematic review of the most important diagnostic and prognostic uses of lead aVR. We performed a thorough review of the literature about the lead aVR using PubMed, MEDLINE and the archives of the University at Buffalo libraries. We found that lead aVR may provide important additional information in the diagnosis of coronary artery disease. It may provide a clue to the location of a lesion as well as the possibility of three vessel disease during an acute coronary syndrome. Lead aVR was found useful in the locus of arrhythmias and in differentiation of narrow and wide QRS complex tachycardias. It provides useful prognostic information for patients with the Brugada syndrome and tricyclic antidepressant toxicity. Lead aVR provides alternative criteria for the electrocardiographic diagnosis of left ventricular hypertrophy and left anterior fascicular block. Lead aVR provides very important additional diagnostic and prognostic information in multiple cardiac conditions and can be used either alone or in conjunction with other electrocardiographic leads.
    Annals of Noninvasive Electrocardiology 04/2010; 15(2):175-80. DOI:10.1111/j.1542-474X.2010.00359.x · 1.08 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Acute coronary syndrome remains the leading cause of morbidity and mortality worldwide. It will continue to rise as the prevalence of patients with obesity and diabetes increases. Patients with non-ST segment elevation acute coronary syndrome had a bad prognosis in patients with left main ± three vessel diseases, so early identification of these patients by electrocardiography if ST segment elevation in lead aVR ⩾0.5 m and maximal QRS duration of ⩾90 ms is important for the selection of optimal treatment.
    06/2011; 63(2):103–107. DOI:10.1016/j.ehj.2011.09.015